Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Cefixime + Azithromycin (Dual Therapy, Oral Alternative)
Treatment for Gonococcal infection
Typical Dosage: Cefixime 800mg oral + Azithromycin 1g oral
Effectiveness
93%
Safety Score
70%
Clinical Trials
85
Participants
11K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Cefixime 800mg oral + Azithromycin 1g oral
Time to Effect
1-3 days
Treatment Duration
Single dose
Evidence Quality
MODERATENumber Needed to Treat (NNT)
1.3(Treat 1.3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
7(Treat 7 patients to see 1 additional serious adverse event)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$40
Monitoring:$150
Side Effect Mgmt:$30
Total Annual:$220
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.04
Outcome-Based Costs
Cost per Responder
$236
Cost per Remission
$236
Comparison vs Ceftriaxone + Azithromycin
Cost Difference
+$25/year
More expensive
QALY Difference
-0.03 QALYs
Worse outcomes
Dominance
No dominance
Cefixime + Azithromycin (Dual Therapy, Oral Alternative) Outcomes
for Gonococcal infection
Efficacy Outcomes
Overall Effectiveness
+93%
Response Rate
+93%
Remission Rate
+93%
Common Side Effects
Diarrhea (Cefixime)
+18%
Nausea (Cefixime)
+7%
Abdominal pain (Cefixime)
+5%
Diarrhea (Azithromycin)
+14%
Headache
+2%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov